754 related articles for article (PubMed ID: 19606937)
21. Valsartan-amlodipine-hydrochlorothiazide: the definitive fixed combination?
Barrios V; Escobar C
Expert Rev Cardiovasc Ther; 2010 Nov; 8(11):1609-18. PubMed ID: 21090936
[TBL] [Abstract][Full Text] [Related]
22. Effects of the angiotensin-1 receptor blocker valsartan compared with amlodipine on renal hemodynamics.
Epstein M; Hollenberg NK
Am J Hypertens; 2004 Jul; 17(7):638-9; author reply 639-40. PubMed ID: 15233985
[No Abstract] [Full Text] [Related]
23. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
[TBL] [Abstract][Full Text] [Related]
24. Is renoprotection by angiotensin receptor blocker dependent on blood pressure?: the Saitama Medical School, Albuminuria Reduction in Diabetics with Valsartan (STAR) study.
Katayama S; Yagi S; Yamamoto H; Yamaguchi M; Izumida T; Noguchi Y; Inaba M; Inukai K
Hypertens Res; 2007 Jun; 30(6):529-33. PubMed ID: 17664856
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and tolerability of combination therapy with valsartan/hydrochlorothiazide in the initial treatment of severe hypertension.
Calhoun DA; Glazer RD; Pettyjohn FS; Coenen PD; Zhao Y; Grosso A
Curr Med Res Opin; 2008 Aug; 24(8):2303-11. PubMed ID: 18593517
[TBL] [Abstract][Full Text] [Related]
26. Amlodipine/valsartan single-pill combination: a prospective, observational evaluation of the real-life safety and effectiveness in the routine treatment of hypertension.
Karpov Y; Dongre N; Vigdorchik A; Sastravaha K
Adv Ther; 2012 Feb; 29(2):134-47. PubMed ID: 22271158
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of fixed-dose combination therapy in the treatment of patients with hypertension: focus on amlodipine/valsartan.
da Silva PM
Clin Drug Investig; 2010; 30(9):625-41. PubMed ID: 20626210
[TBL] [Abstract][Full Text] [Related]
28. The VALUE trial: a commentary.
Sever P
J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):99-101. PubMed ID: 15526243
[TBL] [Abstract][Full Text] [Related]
29. Randomized study to compare valsartan +/- HCTZ versus amlodipine +/- HCTZ strategies to maximize blood pressure control.
Zappe D; Papst CC; Ferber P;
Vasc Health Risk Manag; 2009; 5():883-92. PubMed ID: 19898644
[TBL] [Abstract][Full Text] [Related]
30. Olmesartan/Amlodipine: combination therapy for the treatment of hypertension [corrected].
Pimenta E
Adv Ther; 2009 Jan; 26(1):1-11. PubMed ID: 19129998
[TBL] [Abstract][Full Text] [Related]
31. Novel mechanism and role of angiotensin II induced vascular endothelial injury in hypertensive diastolic heart failure.
Yamamoto E; Kataoka K; Shintaku H; Yamashita T; Tokutomi Y; Dong YF; Matsuba S; Ichijo H; Ogawa H; Kim-Mitsuyama S
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2569-75. PubMed ID: 17932313
[TBL] [Abstract][Full Text] [Related]
32. Comparison of amlodipine/valsartan fixed-dose combination therapy and conventional therapy.
Malesker MA; Hilleman DE
Manag Care; 2010 Jul; 19(7):36-42. PubMed ID: 20672530
[TBL] [Abstract][Full Text] [Related]
33. Reduction of QTc dispersion by the angiotensin II receptor blocker valsartan may be related to its anti-oxidative stress effect in patients with essential hypertension.
Miyajima K; Minatoguchi S; Ito Y; Hukunishi M; Matsuno Y; Kakami M; Kawasaki M; Nishigaki K; Takemura G; Fujiwara H
Hypertens Res; 2007 Apr; 30(4):307-13. PubMed ID: 17541209
[TBL] [Abstract][Full Text] [Related]
34. Combination of amlodipine 10 mg and valsartan 160 mg lowers blood pressure in patients with hypertension not controlled by an ACE inhibitor/CCB combination.
Trenkwalder P; Schaetzl R; Borbas E; Handrock R; Klebs S
Blood Press Suppl; 2008 Dec; 2():13-21. PubMed ID: 19205092
[TBL] [Abstract][Full Text] [Related]
35. Targeting hypertension with valsartan: Lessons learned from the Valsartan/HCTZ versus Amlodipine in stage II hypertensive patients (VASt) trial.
Ruilope LM; Zanchetti A
J Renin Angiotensin Aldosterone Syst; 2006 Jun; 7 Suppl 1():S8-11. PubMed ID: 16986228
[TBL] [Abstract][Full Text] [Related]
36. [A first drug combination for the treatment of arterial hypertension with a calcium channel antagonist (amlodipine besylate) and an angiotensin receptor blocker (valsartan): Exforge].
Krzesinski JM; Scheen AJ
Rev Med Liege; 2007 Nov; 62(11):688-94. PubMed ID: 18217647
[TBL] [Abstract][Full Text] [Related]
37. Effects of force-titrated valsartan/hydrochlorothiazide versus amlodipine/hydrochlorothiazide on ambulatory blood pressure in patients with stage 2 hypertension: the EVALUATE study.
Lacourcière Y; Wright JT; Samuel R; Zappe D; Purkayastha D; Black HR;
Blood Press Monit; 2009 Jun; 14(3):112-20. PubMed ID: 19384192
[TBL] [Abstract][Full Text] [Related]
38. Amlodipine seems to be superior to valsartan in decreasing microalbuminuria in newly diagnosed hypertensive patients: a novel effect to be explained with hyperfiltration?
Ay SA; Cakar M; Karaman M; Balta S; Demirkol S; Unlu M; Kurt O; Altun B; Akhan M; Arslan E; Koc B; Bulucu F
Ren Fail; 2013; 35(3):357-60. PubMed ID: 23297711
[TBL] [Abstract][Full Text] [Related]
39. Controlled release nifedipine and valsartan combination therapy in patients with essential hypertension: the adalat CR and valsartan cost-effectiveness combination (ADVANCE-combi) study.
Saito I; Saruta T;
Hypertens Res; 2006 Oct; 29(10):789-96. PubMed ID: 17283866
[TBL] [Abstract][Full Text] [Related]
40. Adherence with multiple-combination antihypertensive pharmacotherapies in a US managed care database.
Jackson KC; Sheng X; Nelson RE; Keskinaslan A; Brixner DI
Clin Ther; 2008 Aug; 30(8):1558-63. PubMed ID: 18803997
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
